AN2 Therapeutics, Inc. - Common Stock (NQ:ANTX)
3.630
+0.020
(+0.55%)
Streaming Delayed Price
Updated: 2:08 PM EDT, Mar 27, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 194,943 |
| Open | 3.660 |
| Bid (Size) | 3.600 (300) |
| Ask (Size) | 3.650 (200) |
| Prev. Close | 3.610 |
| Today's Range | 3.560 - 4.010 |
| 52wk Range | 1.000 - 6.910 |
| Shares Outstanding | 21,928,452 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Monday's session: top gainers and losers ↗
March 09, 2026
Here are the top movers in Friday's session. ↗
March 06, 2026
Which stocks are moving on Friday? ↗
March 06, 2026
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
September 23, 2025
Frequently Asked Questions
Is AN2 Therapeutics, Inc. - Common Stock publicly traded?
Yes, AN2 Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does AN2 Therapeutics, Inc. - Common Stock trade on?
AN2 Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for AN2 Therapeutics, Inc. - Common Stock?
The ticker symbol for AN2 Therapeutics, Inc. - Common Stock is ANTX on the Nasdaq Stock Market
What is the current price of AN2 Therapeutics, Inc. - Common Stock?
The current price of AN2 Therapeutics, Inc. - Common Stock is 3.630
When was AN2 Therapeutics, Inc. - Common Stock last traded?
The last trade of AN2 Therapeutics, Inc. - Common Stock was at 03/27/26 02:08 PM ET
What is the market capitalization of AN2 Therapeutics, Inc. - Common Stock?
The market capitalization of AN2 Therapeutics, Inc. - Common Stock is 79.60M
How many shares of AN2 Therapeutics, Inc. - Common Stock are outstanding?
AN2 Therapeutics, Inc. - Common Stock has 80M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube